Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screening

Antiviral Research

Volumn 106, Issue 1, 2014, Pages 53-60

  Lo, Michael K ^a   Nichol, Stuart T ^a   Spiropoulou, Christina F ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antiviral screening; GFP; Henipavirus; High throughput screening; Luciferase; Nipah virus

Indexed keywords

ANTIVIRUS AGENT; GREEN FLUORESCENT PROTEIN; LUCIFERASE; RENILLA LUCIFERIN 2 MONOOXYGENASE; VIRUS ANTIGEN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DOSE RESPONSE; FLUORESCENCE; HOST CELL; HUMAN; HUMAN CELL; KINETICS; LIFE CYCLE; LUMINESCENCE; NIPAH VIRUS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STUDY; VIRUS EXPRESSION; WILD TYPE; ANIMAL; CELL LINE; DRUG EFFECTS; DRUG SCREENING; GENETICS; ISOLATION AND PURIFICATION; PROCEDURES; REPORTER GENE; BHK CELL LINE; CELL VIABILITY; CHLOROCEBUS; CONCENTRATION RESPONSE; CYTOPLASM; EMBRYO; FOOT AND MOUTH DISEASE VIRUS; HALF LIFE TIME; HAMSTER; HIGH THROUGHPUT SCREENING; PHENOTYPE; PROTEIN PROCESSING; SIGNAL NOISE RATIO; SIGNAL TRANSDUCTION; UBIQUITINATION; VERO CELL LINE; VIRUS PARTICLE;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DRUG EVALUATION, PRECLINICAL; GENES, REPORTER; HUMANS; LUCIFERASES, RENILLA; LUMINESCENT MEASUREMENTS; NIPAH VIRUS;

EID: 84898657980     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.03.011     Document Type: Article

References (31)

1. M. Aljofan, M. Porotto, A. Moscona, and B.A. Mungall Development and validation of a chemiluminescent immunodetection assay amenable to high throughput screening of antiviral drugs for Nipah and Hendra virus J. Virol. Methods 149 2008 12 19
2. V.H. Bono Jr., S.M. Weissman, and E. Frei 3rd The effect of 6-azauridine administration on De Novo pyrimidine production in chronic myelogenous leukemia J. Clin. Investig. 43 1964 1486 1494
3. K.N. Bossart, B.A. Mungall, G. Crameri, L.F. Wang, B.T. Eaton, and C.C. Broder Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein Virol. J. 2 2005 57
4. C.C. Broder, K. Xu, D.B. Nikolov, Z. Zhu, D.S. Dimitrov, D. Middleton, J. Pallister, T.W. Geisbert, K.N. Bossart, and L.F. Wang A treatment for and vaccine against the deadly Hendra and Nipah viruses Antiviral Res. 100 2013 8 13
5. U.J. Buchholz, S. Finke, and K.K. Conzelmann Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter J. Virol. 73 1999 251 259 (Pubitemid 28565367)
6. C.F. Chiang, M.K. Lo, P.A. Rota, C.F. Spiropoulou, and P.E. Rollin Use of monoclonal antibodies against Hendra and Nipah viruses in an antigen capture ELISA Virol. J. 7 2010 115
7. P. Corish, and C. Tyler-Smith Attenuation of green fluorescent protein half-life in mammalian cells Protein Eng. 12 1999 1035 1040 (Pubitemid 30011478)
8. K.P. Dhondt, C. Mathieu, M. Chalons, J.M. Reynaud, A. Vallve, H. Raoul, and B. Horvat Type I interferon signaling protects mice from lethal henipavirus infection J. Infect. Dis. 207 2013 142 151
9. O. Escaffre, V. Borisevich, J.R. Carmical, D. Prusak, J. Prescott, H. Feldmann, and B. Rockx Henipavirus pathogenesis in human respiratory epithelial cells J. Virol. 87 2013 3284 3294
10. A. Freiberg, L.K. Dolores, S. Enterlein, and R. Flick Establishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNA Virology 370 2008 33 44 (Pubitemid 350179908)
11. M.C. Georges-Courbot, H. Contamin, C. Faure, P. Loth, S. Baize, P. Leyssen, J. Neyts, and V. Deubel Poly(I)-poly(C12U) but not ribavirin prevents death in a hamster model of Nipah virus infection Antimicrob. Agents Chemother. 50 2006 1768 1772
12. G.E. Gutowski, M.J. Sweeney, D.C. DeLong, R.L. Hamill, K. Gerzon, and R.W. Dyke Biochemistry and biological effects of the pyrazofurins (pyrazomycins): initial clinical trial Ann. N. Y. Acad. Sci. 255 1975 544 551
13. J.H. Kim, S.R. Lee, L.H. Li, H.J. Park, J.H. Park, K.Y. Lee, M.K. Kim, B.A. Shin, and S.Y. Choi High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice PLoS ONE 6 2011 e18556
14. D. Kolakofsky, T. Pelet, D. Garcin, S. Hausmann, J. Curran, and L. Roux Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited J. Virol. 72 1998 891 899 (Pubitemid 28116865)
15. S. Kulkarni, V. Volchkova, C.F. Basler, P. Palese, V.E. Volchkov, and M.L. Shaw Nipah virus edits its P gene at high frequency to express the V and W proteins J. Virol. 83 2009 3982 3987
16. M.K. Lo, M.E. Peeples, W.J. Bellini, S.T. Nichol, P.A. Rota, and C.F. Spiropoulou Distinct and overlapping roles of Nipah virus P gene products in modulating the human endothelial cell antiviral response PLoS ONE 7 2012 e47790
17. A.M. Loening, T.D. Fenn, A.M. Wu, and S.S. Gambhir Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output Protein Eng. Des. Sel. 19 2006 391 400 (Pubitemid 44306057)
18. S.P. Luby The pandemic potential of Nipah virus Antiviral Res. 100 2013 38 43
19. G.A. Marsh, E.R. Virtue, I. Smith, S. Todd, R. Arkinstall, L. Frazer, P. Monaghan, G.A. Smith, C.C. Broder, D. Middleton, and L.F. Wang Recombinant Hendra viruses expressing a reporter gene retain pathogenicity in ferrets Virol. J. 10 2013 95
20. N. Nahar, U.K. Mondal, R. Sultana, M.J. Hossain, M.S. Khan, E.S. Gurley, E. Oliveras, and S.P. Luby Piloting the use of indigenous methods to prevent Nipah virus infection by interrupting bats' access to date palm sap in Bangladesh Health Promot. Int. 28 2013 378 386
21. M. Porotto, G. Orefice, C.C. Yokoyama, B.A. Mungall, R. Realubit, M.L. Sganga, M. Aljofan, M. Whitt, F. Glickman, and A. Moscona Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy J. Virol. 83 2009 5148 5155
22. J.J. Rodriguez, J.P. Parisien, and C.M. Horvath Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation J. Virol. 76 2002 11476 11483 (Pubitemid 35231304)
23. P.A. Rota, and M.K. Lo Molecular virology of the henipaviruses Curr. Top. Microbiol. Immunol. 359 2012 41 58
24. M.L. Shaw, W.B. Cardenas, D. Zamarin, P. Palese, and C.F. Basler Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways J. Virol. 79 2005 6078 6088 (Pubitemid 40617213)
25. A. Talekar, A. Pessi, F. Glickman, U. Sengupta, T. Briese, M.A. Whitt, C. Mathieu, B. Horvat, A. Moscona, and M. Porotto Rapid screening for entry inhibitors of highly pathogenic viruses under low-level biocontainment PLoS ONE 7 2012 e30538
26. A. Tamin, B.H. Harcourt, M.K. Lo, J.A. Roth, M.C. Wolf, B. Lee, H. Weingartl, J.C. Audonnet, W.J. Bellini, and P.A. Rota Development of a neutralization assay for Nipah virus using pseudotype particles J. Virol. Methods 160 2009 1 6
27. E.R. Virtue, G.A. Marsh, and L.F. Wang Interferon signaling remains functional during henipavirus infection of human cell lines J. Virol. 85 2011 4031 4034
28. Y.E. Wang, A. Park, M. Lake, M. Pentecost, B. Torres, T.E. Yun, M.C. Wolf, M.R. Holbrook, A.N. Freiberg, and B. Lee Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding PLoS Pathog. 6 2010 e1001186
29. D. Yan, S.A. Krumm, A. Sun, D.A. Steinhauer, M. Luo, M.L. Moore, and R.K. Plemper Dual myxovirus screen identifies a small-molecule agonist of the host antiviral response J. Virol. 87 2013 11076 11087
30. M. Yoneda, V. Guillaume, F. Ikeda, Y. Sakuma, H. Sato, T.F. Wild, and C. Kai Establishment of a Nipah virus rescue system Proc. Nat. Acad. Sci. U.S.A. 103 2006 16508 16513 (Pubitemid 44715226)
31. J.H. Zhang, T.D. Chung, and K.R. Oldenburg A simple statistical parameter for use in evaluation and validation of high throughput screening assays J. Biomol. Screen. 4 1999 67 73 (Pubitemid 29278954)